GORE-TEX REGENERATIVE MATERIAL TITANIUM REINFORCED CONFIGURATIONS

K960292 · W. L. Gore & Associates, Inc. · NPK · Apr 15, 1996 · Dental

Device Facts

Record IDK960292
Device NameGORE-TEX REGENERATIVE MATERIAL TITANIUM REINFORCED CONFIGURATIONS
ApplicantW. L. Gore & Associates, Inc.
Product CodeNPK · Dental
Decision DateApr 15, 1996
DecisionSESE
Submission TypeTraditional
Regulation21 CFR 872.3930
Device ClassClass 2
AttributesTherapeutic

Intended Use

GORE-TEX Regenerative Material is intended to provide a mechanism for the ingrowth of new hard and soft tissues into bony defects surrounding teeth and to augment ingrowth of hard and soft tissues on alveolar ridges. GORE-TEX Regenerative Material is a passive, non-load bearing material. It is NOT intended for use in load bearing, articulating situations such as temporal mandibular joint reconstruction.

Device Story

GORE-TEX Regenerative Material is a non-resorbable, passive barrier membrane used in oral surgery. It is surgically placed beneath the muco-periosteum to isolate bone or bone/periodontal ligament defects. The device acts as a physical barrier, excluding epithelial and gingival connective tissue to allow desirable cell repopulation. It features titanium reinforcement to provide structural stiffness for space-making while remaining supple enough for draping over defect margins. The device is non-load bearing and is not intended for articulating joints. It benefits patients by promoting predictable hard and soft tissue regeneration in the oral cavity.

Clinical Evidence

Bench testing only. Performance data focused on lamination bond strength testing to ensure the modified configuration meets or exceeds the performance of the predicate device.

Technological Characteristics

Non-resorbable barrier membrane; titanium-reinforced; passive, non-load bearing; biocompatible; cell-occlusive; designed for space-making and tissue integration; manual surgical placement.

Indications for Use

Indicated for patients requiring guided tissue regeneration (GTR) to facilitate ingrowth of hard and soft tissues into bony defects surrounding teeth and for augmentation of alveolar ridges.

Regulatory Classification

Identification

Bone grafting material is a material such as hydroxyapatite, tricalcium phosphate, polylactic and polyglycolic acids, or collagen, that is intended to fill, augment, or reconstruct periodontal or bony defects of the oral and maxillofacial region.

Special Controls

*Classification.* (1) Class II (special controls) for bone grafting materials that do not contain a drug that is a therapeutic biologic. The special control is FDA's “Class II Special Controls Guidance Document: Dental Bone Grafting Material Devices.” (See § 872.1(e) for the availability of this guidance document.)(2) Class III (premarket approval) for bone grafting materials that contain a drug that is a therapeutic biologic. Bone grafting materials that contain a drug that is a therapeutic biologic, such as biological response modifiers, require premarket approval. (c) *Date premarket approval application (PMA) or notice of product development protocol (PDP) is required.* Devices described in paragraph (b)(2) of this section shall have an approved PMA or a declared completed PDP in effect before being placed in commercial distribution.

Predicate Devices

Related Devices

Submission Summary (Full Text)

{0} HUMAN SERVICES DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service OCT 10 2007 Food and Drug Administration 9200 Corporate Boulevard Rockville, Maryland 20850 Ms. Jacqueline Kalbach Regulatory Affairs Associate W.L. Gore & Associates, Incorporated 1500 North Fourth Street Flagstaff, Arizona 86001 Re: K960292 Trade Name: Gore-Tex Regenerative Material Titanium Reinforced Configurations Regulation Number: 872.3930 Regulation Name: Bone Grafting Material Regulatory Class: 2 Product Code: NPK Dated: January 19, 1996 Received: January 22, 1996 Dear Ms. Kalbach: This letter corrects our substantially equivalent letter of April 15, 1996. We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. {1} Page 2 – Please be advised that FDA’s issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act’s requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (sections 531-542 of the Act); 21 CFR 1000-1050. This letter will allow you to continue marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (240) 276-0115. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html Sincerely yours, ![img-0.jpeg](img-0.jpeg) Chiu Lin, Ph.D. Director Division of Anesthesiology, General Hospital, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health ![img-1.jpeg](img-1.jpeg) Protecting and Promoting Public Health {2} 510(k) SUMMARY OF SAFETY AND EFFECTIVENESS K960292 K960292 1. **Applicant Name, Address**: W.L. Gore & Associates, Inc. 1500 North Fourth Street P.O. Box 2500 Flagstaff AZ 86003-2500 APR 15 1996 **Contact Person, Telephone**: Jacqueline Kalbach (520)527-2295 **Date of Summary**: January 19, 1996 2. **Classification Name**: Nonresorbable Barrier Membrane **Common or Usual Name**: Regenerative Material **Proprietary Name**: GORE-TEX Regenerative Material -- Titanium Reinforced Configurations 3. **Predicate Device**: GORE-TEX Periodontal Material -- Titanium Reinforced Configurations 4. **Device Description**: The Titanium Reinforced Configurations of GORE-TEX Regenerative Material are designed to act in accordance with the accepted principles of wound healing and guided tissue regeneration (GTR). Specifically, the device is designed to be biocompatible, cell occlusive, spacemaking, and clinically manageable, and allow for tissue integration. The materials used in the manufacture of the Titanium Reinforced Configurations do not alter the biology of GTR therapy or the application for which the product is presently used. GORE-TEX Regenerative Material is surgically placed beneath the muco-periosteum to aid in the regenerative healing of (1) bone or (2) bone/periodontal {3} ligament defects of the oral cavity. The material is designed to be a passive barrier which excludes epithelial and gingival connective tissue from the defect site so that only the desirable cells repopulate the space, allowing regeneration to occur. The material is designed to be stiff enough to create and maintain a protected defect space into which new hard and soft tissues can form, but supple enough to drape smoothly over the defect margin. It is non-absorbable, thereby allowing for predictable isolation of the defect site. 5. **Intended Use:** GORE-TEX Regenerative Material is intended to provide a mechanism for the ingrowth of new hard and soft tissues into bony defects surrounding teeth and to augment ingrowth of hard and soft tissues on alveolar ridges. GORE-TEX Regenerative Material is a passive, non-load bearing material. It is NOT intended for use in load bearing, articulating situations such as temporal mandibular joint reconstruction. 6. **Technological Characteristics:** The modified Titanium Reinforced Configurations of GORE-TEX Regenerative Material have been designed according to the same five design criteria as the predicate device, GORE-TEX Periodontal Material -- Titanium Reinforced Configurations. The additional raw material has reduced the complexity of the manufacturing process. {4} 7. Assessment of Performance Data: Lamination is an important characteristic and testing of the lamination bond strength was performed. The bond values for the modified Titanium Reinforced Configurations are comparable to or better than those of the current Titanium Reinforced Configurations. 8. Conclusion: The modified Titanium Reinforced Configurations of GORE-TEX Regenerative Material are substantially equivalent to the current Titanium Reinforced Configurations of GORE-TEX Regenerative Material in design, manufacturing process, materials, and intended use.
Innolitics
510(k) Summary
Decision Summary
Classification Order
Enter a record ID and click Load to view the document.
100%